5/2/19: LENSAR ® Laser System Receives FDA Clearance to Perform Micro Radial Incisions to Optimize Outcomes of Refractive Cataract Procedures

LENSAR, Inc. has announced it received 510(k) clearance from the U.S. Food and Drug Administration for the LENSAR® Laser System with Streamline® IV, expanding the platform’s capabilities to include the creation of micro radial incisions that allow surgeons to treat additional corneal conditions post cataract surgery.

LENSAR® Laser System Receives FDA Clearance to Perform Corneal Pockets and Flaps for Corneal Inlay Procedures

4/11/12: Lensar Laser System with Streamline™ IV expands the powerful refractive cataract femtosecond platform to support the surgical treatment of presbyopia.